Coronavirus and kidney disease
Our coronavirus and kidney disease hub pulls together all our work related to Covid-19.
Get the latest information about Covid-19 kidney research we are funding and how the charity has been affected by the pandemic.
Get answers to some of the questions we are asked most frequently about the Covid-19 vaccines.
Staying safe as lockdown eases
The Kidney Charities Together Group have teamed up to provide you with the information you need to stay safe.
Covid-19 vaccines and kidney disease
Take a look at our Covid-19 vaccine information, find out how vaccines help protect you and read our frequently asked questions.
Can a tapeworm drug protect high risk kidney patients from Covid-19?
We are helping to fund a clinical trial to find out if the drug niclosamide, usually used to treat tapeworms, can prevent Covid-19 infection in vulnerable, high risk kidney patients and reduce the number of people who become seriously ill or die from it.
New study will reveal how well Covid-19 vaccines protect dialysis patients
Kidney Research UK, the National Kidney Federation (NKF), Kidney Wales and the PKD Charity have joined forces to fund a new research study to discover how well Covid-19 vaccines work in people who go to hospital for their dialysis treatment (haemodialysis).
Support for healthcare professionals
Our colleagues at the UK Kidney Association have just released new guidance for healthcare professionals looking after clinically extremely vulnerable kidney patients, which we are happy to endorse.
Staying safe at work
People shouldn’t feel like they are being forced into Covid unsafe workplaces so we have joined a charity coalition to create a resource to help. Share this letter with your employer if you are anxious.
Your donation is more critical than ever
Every minute last year we spent £16.21 on research. With your support we can make sure life-saving research continues.